Evidence map›Paper›PMID 34840952›Full record

ArticleIDCases2021

Chronic-Relapsing cutaneous leukocytoclastic vasculitis in a young patient with reduced EBV-specific T cell response using enzyme-linked immunospot (ELISPOT) assay successfully treated with Valaciclovir.

Caterina Foti, Elvira Favoino, Maria Scarasciulli, Anna Maria Colacicco, Hamidreza Jahantigh, Angela Stufano, Piero Lovreglio, Paola Mascia, Chiara Barlusconi, Federico Perosa and 2 more

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in IDCases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 76% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Caterina FotiDepartment of Biomedical Science and Human Oncology, Dermatological Clinic, University of Bari "Aldo Moro", Bari, Italy.
Elvira FavoinoDepartment of Biomedical Science and Human Oncology (DIMO), Rheumatic and Systemic Autoimmune Diseases Unit, University of Bari Medical School, Bari, Italy.
Maria ScarasciulliMicrobiology and Virology Unit - Interdisciplinary Department of Medicine (DIM) - University of Bari "Aldo Moro"- AOU Policlinico Bari, Italy.
Anna Maria ColaciccoMicrobiology and Virology Unit - Interdisciplinary Department of Medicine (DIM) - University of Bari "Aldo Moro"- AOU Policlinico Bari, Italy.
Hamidreza JahantighInterdisciplinary Department of Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.
Angela StufanoInterdisciplinary Department of Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.
Piero LovreglioInterdisciplinary Department of Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.
Paola MasciaDepartment of Biomedical Science and Human Oncology, Dermatological Clinic, University of Bari "Aldo Moro", Bari, Italy.
Chiara BarlusconiDepartment of Biomedical Science and Human Oncology, Dermatological Clinic, University of Bari "Aldo Moro", Bari, Italy.
Federico PerosaDepartment of Biomedical Science and Human Oncology (DIMO), Rheumatic and Systemic Autoimmune Diseases Unit, University of Bari Medical School, Bari, Italy.
Paolo RomitaDepartment of Biomedical Science and Human Oncology, Dermatological Clinic, University of Bari "Aldo Moro", Bari, Italy.
Agata CalvarioMicrobiology and Virology Unit - Interdisciplinary Department of Medicine (DIM) - University of Bari "Aldo Moro"- AOU Policlinico Bari, Italy.
University of Bari Aldo Moro · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Among different pathogens, opportunistic viral infection caused by EBV is particularly relevant. This gammaherpesvirus, belonging to the Herpesviridae family, may complicate the disease course in different clinical settings by inducing pathological EBV pictures in patients with a defective immunologic response. Our report evaluated EBV-specific T cell responses by IFN- γ ELISPOT assay, which revealed defective EBV specific immunological response.

Identifiers

PMID34840952
PMCPMC8605419
OpenAlexW3214537267

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.